Vaccination Against Human Papillomavirus
CLINICAL QUESTION: Who should receive human papillomavirus (HPV) vaccination? BOTTOM LINE: Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now jointly decide whether HPV vaccination is appropriate. Rou...
Gespeichert in:
| Veröffentlicht in: | Archives of dermatology (1960) 2020-11, Vol.156 (11), p.1246-1247 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1247 |
|---|---|
| container_issue | 11 |
| container_start_page | 1246 |
| container_title | Archives of dermatology (1960) |
| container_volume | 156 |
| creator | Marks, Dustin H Katz, Kenneth A |
| description | CLINICAL QUESTION: Who should receive human papillomavirus (HPV) vaccination? BOTTOM LINE: Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now jointly decide whether HPV vaccination is appropriate. Routine HPV vaccination at age 11 or 12 years (or as early as age 9 years) continues to be recommended. |
| doi_str_mv | 10.1001/jamadermatol.2020.2927 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2436404493</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2769109</ama_id><sourcerecordid>2464864835</sourcerecordid><originalsourceid>FETCH-LOGICAL-a358t-3ff2fb2f52ef5dc4dac6176ab15b7264f0969f85afbf516e17e281faf22f0a413</originalsourceid><addsrcrecordid>eNpdkE1LAzEURYMottT-ARel4KabqcnLx2SWpagVBF2o2_BmJpEp81GTGcF_b0prEUMgD965l3AImTG6ZJSy2y02WFrfYN_VS6BAl5BBekbGwJROFNXi_DQrPSLTELY0Hk2p4OySjDhoACHFmCzesSiqFvuqa-erD6za0M83Q4Pt_AV3VV13DX5VfghX5MJhHez0-E7I2_3d63qTPD0_PK5XTwlyqfuEOwcuByfBOlkWosRCsVRhzmSeghKOZipzWqLLnWTKstSCZg4dgKMoGJ-QxaF357vPwYbeNFUobF1ja7shGBBcCSpExiN68w_ddoNv4-8ipYSOl8tIqQNV-C4Eb53Z-apB_20YNXud5q9Os9dp9jpjcHasH_LGlqfYr7wIXB-AmD9tIVUZoxn_AeQuezg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2464864835</pqid></control><display><type>article</type><title>Vaccination Against Human Papillomavirus</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Marks, Dustin H ; Katz, Kenneth A</creator><creatorcontrib>Marks, Dustin H ; Katz, Kenneth A</creatorcontrib><description>CLINICAL QUESTION: Who should receive human papillomavirus (HPV) vaccination? BOTTOM LINE: Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now jointly decide whether HPV vaccination is appropriate. Routine HPV vaccination at age 11 or 12 years (or as early as age 9 years) continues to be recommended.</description><identifier>ISSN: 2168-6068</identifier><identifier>EISSN: 2168-6084</identifier><identifier>DOI: 10.1001/jamadermatol.2020.2927</identifier><identifier>PMID: 32822454</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Adolescent ; Adult ; Adults ; Advisory Committees - standards ; Centers for Disease Control and Prevention, U.S. - standards ; Child ; Evidence-Based Medicine - standards ; Female ; Human papillomavirus ; Humans ; Immunization ; Immunization Schedule ; Male ; Mass Vaccination - standards ; Papillomavirus Infections - epidemiology ; Papillomavirus Infections - prevention & control ; Papillomavirus Infections - virology ; Papillomavirus Vaccines - administration & dosage ; Pediatrics ; Practice Guidelines as Topic ; Teenagers ; United States - epidemiology ; Vaccines ; Womens health ; Young Adult</subject><ispartof>Archives of dermatology (1960), 2020-11, Vol.156 (11), p.1246-1247</ispartof><rights>Copyright American Medical Association Nov 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a358t-3ff2fb2f52ef5dc4dac6176ab15b7264f0969f85afbf516e17e281faf22f0a413</citedby><cites>FETCH-LOGICAL-a358t-3ff2fb2f52ef5dc4dac6176ab15b7264f0969f85afbf516e17e281faf22f0a413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamadermatology/articlepdf/10.1001/jamadermatol.2020.2927$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2020.2927$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3340,27924,27925,76489,76492</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32822454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marks, Dustin H</creatorcontrib><creatorcontrib>Katz, Kenneth A</creatorcontrib><title>Vaccination Against Human Papillomavirus</title><title>Archives of dermatology (1960)</title><addtitle>JAMA Dermatol</addtitle><description>CLINICAL QUESTION: Who should receive human papillomavirus (HPV) vaccination? BOTTOM LINE: Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now jointly decide whether HPV vaccination is appropriate. Routine HPV vaccination at age 11 or 12 years (or as early as age 9 years) continues to be recommended.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Adults</subject><subject>Advisory Committees - standards</subject><subject>Centers for Disease Control and Prevention, U.S. - standards</subject><subject>Child</subject><subject>Evidence-Based Medicine - standards</subject><subject>Female</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Schedule</subject><subject>Male</subject><subject>Mass Vaccination - standards</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Papillomavirus Infections - prevention & control</subject><subject>Papillomavirus Infections - virology</subject><subject>Papillomavirus Vaccines - administration & dosage</subject><subject>Pediatrics</subject><subject>Practice Guidelines as Topic</subject><subject>Teenagers</subject><subject>United States - epidemiology</subject><subject>Vaccines</subject><subject>Womens health</subject><subject>Young Adult</subject><issn>2168-6068</issn><issn>2168-6084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkE1LAzEURYMottT-ARel4KabqcnLx2SWpagVBF2o2_BmJpEp81GTGcF_b0prEUMgD965l3AImTG6ZJSy2y02WFrfYN_VS6BAl5BBekbGwJROFNXi_DQrPSLTELY0Hk2p4OySjDhoACHFmCzesSiqFvuqa-erD6za0M83Q4Pt_AV3VV13DX5VfghX5MJhHez0-E7I2_3d63qTPD0_PK5XTwlyqfuEOwcuByfBOlkWosRCsVRhzmSeghKOZipzWqLLnWTKstSCZg4dgKMoGJ-QxaF357vPwYbeNFUobF1ja7shGBBcCSpExiN68w_ddoNv4-8ipYSOl8tIqQNV-C4Eb53Z-apB_20YNXud5q9Os9dp9jpjcHasH_LGlqfYr7wIXB-AmD9tIVUZoxn_AeQuezg</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Marks, Dustin H</creator><creator>Katz, Kenneth A</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20201101</creationdate><title>Vaccination Against Human Papillomavirus</title><author>Marks, Dustin H ; Katz, Kenneth A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a358t-3ff2fb2f52ef5dc4dac6176ab15b7264f0969f85afbf516e17e281faf22f0a413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Adults</topic><topic>Advisory Committees - standards</topic><topic>Centers for Disease Control and Prevention, U.S. - standards</topic><topic>Child</topic><topic>Evidence-Based Medicine - standards</topic><topic>Female</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Schedule</topic><topic>Male</topic><topic>Mass Vaccination - standards</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Papillomavirus Infections - prevention & control</topic><topic>Papillomavirus Infections - virology</topic><topic>Papillomavirus Vaccines - administration & dosage</topic><topic>Pediatrics</topic><topic>Practice Guidelines as Topic</topic><topic>Teenagers</topic><topic>United States - epidemiology</topic><topic>Vaccines</topic><topic>Womens health</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marks, Dustin H</creatorcontrib><creatorcontrib>Katz, Kenneth A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of dermatology (1960)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marks, Dustin H</au><au>Katz, Kenneth A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccination Against Human Papillomavirus</atitle><jtitle>Archives of dermatology (1960)</jtitle><addtitle>JAMA Dermatol</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>156</volume><issue>11</issue><spage>1246</spage><epage>1247</epage><pages>1246-1247</pages><issn>2168-6068</issn><eissn>2168-6084</eissn><abstract>CLINICAL QUESTION: Who should receive human papillomavirus (HPV) vaccination? BOTTOM LINE: Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now jointly decide whether HPV vaccination is appropriate. Routine HPV vaccination at age 11 or 12 years (or as early as age 9 years) continues to be recommended.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>32822454</pmid><doi>10.1001/jamadermatol.2020.2927</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-6068 |
| ispartof | Archives of dermatology (1960), 2020-11, Vol.156 (11), p.1246-1247 |
| issn | 2168-6068 2168-6084 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2436404493 |
| source | MEDLINE; American Medical Association Journals |
| subjects | Adolescent Adult Adults Advisory Committees - standards Centers for Disease Control and Prevention, U.S. - standards Child Evidence-Based Medicine - standards Female Human papillomavirus Humans Immunization Immunization Schedule Male Mass Vaccination - standards Papillomavirus Infections - epidemiology Papillomavirus Infections - prevention & control Papillomavirus Infections - virology Papillomavirus Vaccines - administration & dosage Pediatrics Practice Guidelines as Topic Teenagers United States - epidemiology Vaccines Womens health Young Adult |
| title | Vaccination Against Human Papillomavirus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T09%3A17%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccination%20Against%20Human%20Papillomavirus&rft.jtitle=Archives%20of%20dermatology%20(1960)&rft.au=Marks,%20Dustin%20H&rft.date=2020-11-01&rft.volume=156&rft.issue=11&rft.spage=1246&rft.epage=1247&rft.pages=1246-1247&rft.issn=2168-6068&rft.eissn=2168-6084&rft_id=info:doi/10.1001/jamadermatol.2020.2927&rft_dat=%3Cproquest_cross%3E2464864835%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2464864835&rft_id=info:pmid/32822454&rft_ama_id=2769109&rfr_iscdi=true |